Serbia began vaccinations with Sputnik in early January.

The Russian Direct Investment Fund (RDIF) said on March 24 it has signed an agreement with Serbian vaccines institute Torlak to produce the Sputnik V coronavirus vaccine in Serbia.

Moscow in April announced the start of production of its Sputnik V coronavirus vaccine in Serbia, the first European country outside Russia and Belarus to begin manufacturing the jab. On May 19, Russia's Gamaleya National Research Institute confirmed the quality of the Sputnik V trial vaccine manufactured in Torlak Institute.